Insider · CIK 0002143921
Jeffery Keeslar Harris
Files at ZSQR (Coeptis Therapeutics Holdings, Inc.). First filing -, latest -.
In brief
Jeffery Keeslar Harris files SEC Form 4 as officer at ZSQR (Coeptis Therapeutics Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeffery Keeslar Harris has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | 8 d ago |
| Sep 24, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Common Stock | +12,444 | $0.00 | $0 | 12,444 | 11 d ago |
| Sep 24, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -12,444 | $0.00 | $0 | 37,334 | 11 d ago |
| Aug 24, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +49,778 | $0.00 | $0 | 49,778 | Aug 25, 2026 |
Questions about Jeffery Keeslar Harris
Answered from the filings on this page, as of the latest one.
Is Jeffery Keeslar Harris buying or selling?
Jeffery Keeslar Harris has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeffery Keeslar Harris's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffery Keeslar Harris has 0.
Where does Jeffery Keeslar Harris file Form 4?
Jeffery Keeslar Harris has filed Form 4 at ZSQR (Coeptis Therapeutics Holdings, Inc.) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.